GATA3 and allergic asthma: Butyrate is considered an anti-allergic asthma treatment, which suppresses pro-inflammatory cytokines secretion and GATA binding protein 3 (GATA3) expression in the human pulmonary Group 2 Innate lymphoid cells (ILC2s) [82].